Technopedia Center
PMB University Brochure
Faculty of Engineering and Computer Science
S1 Informatics S1 Information Systems S1 Information Technology S1 Computer Engineering S1 Electrical Engineering S1 Civil Engineering

faculty of Economics and Business
S1 Management S1 Accountancy

Faculty of Letters and Educational Sciences
S1 English literature S1 English language education S1 Mathematics education S1 Sports Education
teknopedia

Flag Counter
  2. World Encyclopedia
  3. Breakout Ventures - Wikipedia
Breakout Ventures - Wikipedia
From Wikipedia, the free encyclopedia
(Redirected from Breakout Labs)
Breakout Ventures
Founded2016
Headquarters38 Mesa St.,
San Francisco, CA
Websitebreakout.vc

Breakout Ventures is a privately held venture capital firm founded in 2016. The firm was founded out of Breakout Labs, a program of the Thiel Foundation (a philanthropic organization created by Peter Thiel).[1] The firm is headquartered in San Francisco, California.

Breakout Ventures invests in early-stage companies across technology, biology, and chemistry sectors to build solutions for human health and sustainability. The firm supports science-driven companies moving with urgency throughout their entire life cycle, from seed to scale.[2]

History

Breakout Labs was launched in November 2011.[3] Breakout Labs issued convertible grants[4] for early-stage commercialization of scientific research that was considered too speculative or long-term to interest the for-profit sector (such as angel investors and venture capitalists) but may have been unsuitable for traditional sources of funding for scientific research due to its radical or offbeat nature.[5] Grants were made through a competitive application and selection process.[6]

Breakout Labs announced its first batch of grantees on April 17, 2012,[7] its second batch of grantees on August 15, 2012,[8] and its third batch of grantees in April 2013.[9]

In 2016, Breakout Ventures was founded as a separate entity to provide traditional venture capital investments in science-driven companies, utilizing the Breakout Labs grant program as a way to identify investment opportunities[10]

In 2017, Breakout Ventures closed its debut fund was closed with US$60.1 million in commitments.[11]

In 2021, Breakout Labs formerly closed, having provided 50 science focused grants in the program’s 10 year span.[12]

In December 2021, Breakout Venture's second fund was oversubscribed with US$112.5 million in commitments.[13]

Portfolio

The firm focuses on Series-A and Series-B stage science-driven companies. Its financial partners include Founders Fund, Formation 8, OATV, Lux Capital, Khosla Ventures among others.[14] Some of its recent investments include Noetik (cancer treatment),[15] Cytovale (medical diagnostics),[16] Passkey Therapeutics (synergistic multifunctional therapeutics),[17] Corpernic Catalysts (catalysts for ammonia production),[18] EnPlusOne Biosciences (RNA therapeutics),[19] Phantom Neuro (neurotechnology).[20]

References

  1. ^ Loizos, Connie (2017-09-14). "Breakout Ventures, spun out of Peter Thiel's Breakout Labs, has closed its debut fund with $60M". TechCrunch. Retrieved 2024-11-23.
  2. ^ "Homepage". www.breakout.vc. Retrieved 2025-10-30.
  3. ^ "Thiel Foundation's Breakout Labs Announces Newest Grants at the Intersection of Biology and Advanced Technologies | Fierce Biotech". www.fiercebiotech.com. 15 August 2012. Retrieved 27 July 2025.
  4. ^ Parthasarathy, Hemai; Fishburne, Lindy (2015). "Philanthropy's role in translating scientific innovation". Nature Biotechnology. 33 (10): 1022–1025. doi:10.1038/nbt.3369. ISSN 1087-0156.
  5. ^ "About Us page on Breakout Labs". Archived from the original on 2012-02-27. Retrieved 2012-06-08.
  6. ^ "FAQs page on Breakout Labs". Archived from the original on 2012-02-27. Retrieved 2012-06-08.
  7. ^ "Breakout Labs Announces First Grantees". Breakout Labs. 2012-04-17. Archived from the original on 2012-06-16. Retrieved 2012-06-08.
  8. ^ "Thiel Foundation's Breakout Labs Announces Newest Grants at the Intersection of Biology and Advanced Technologies". Breakout Labs. 2012-08-15. Archived from the original on 2012-10-13. Retrieved 2012-08-15.
  9. ^ Cutler, Kim-Mai (2013-04-17). "Peter Thiel's Breakout Labs Funds "Nanostraws" And A Siri-Like Natural Language Processing Startup". TechCrunch. Retrieved 2013-04-17.
  10. ^ "Breakout Ventures Announces Close of $112.5M Fund II". 9 December 2021. Retrieved 27 July 2025.
  11. ^ Loizos, Connie (14 September 2017). "Breakout Ventures, spun out of Peter Thiel's Breakout Labs, has closed its debut fund with $60M". TechCrunch. Retrieved 27 July 2025.
  12. ^ "Peter Thiel's 'audacious' early-stage science Breakout Labs fund is winding down". www.bizjournals.com. Retrieved 2024-02-19.
  13. ^ "Breakout Ventures closes USD112.5m Fund II - Private Equity Wire". 10 December 2021. Retrieved 27 July 2025.
  14. ^ "Breakout Labs looking for robots that can change the world". Robohub. Retrieved 27 July 2025.
  15. ^ Dorbian, Iris (29 August 2024). "Biotech firm Noetik fetches $40m Series A". Venture Capital Journal. Retrieved 27 July 2025.
  16. ^ "Cytovale Completes $100 Million Series D Funding to Accelerate Commercial Expansion of its Rapid Sepsis Solution". www.prnewswire.com. 10 October 2024. Retrieved 27 July 2025.
  17. ^ "Passkey Therapeutics Raises $20M in Funding". FinSMEs. 22 October 2024. Retrieved 27 July 2025.
  18. ^ "Copernic Catalysts Closes $8M Seed Prime Led by Breakout Ventures to Scale Its Transformational Catalyst for Sustainable Ammonia Production". 12 November 2024. Retrieved 27 July 2025.
  19. ^ Bluemner, Paul (21 February 2025). "EnPlusOne Biosciences Raises $10M Financing". citybiz. Retrieved 27 July 2025.
  20. ^ Lunden, Ingrid (15 April 2025). "Phantom Neuro grabs $19M to help amputees put their phantom limbs to use". TechCrunch.
Sunting pranala
url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url
Pusat Layanan

UNIVERSITAS TEKNOKRAT INDONESIA | ASEAN's Best Private University
Jl. ZA. Pagar Alam No.9 -11, Labuhan Ratu, Kec. Kedaton, Kota Bandar Lampung, Lampung 35132
Phone: (0721) 702022
Email: pmb@teknokrat.ac.id